title: Changes in endocrinological functions in hemodialysis patients associated with improvements in anemia after recombinant human erythropoietin therapy.
authors.affiliation: Department of Internal Medicine, Showa University Fujigaoka Hospital, Yokohama, Japan.
authors.forename: T
authors.initials: T
authors.lastname: Akizawa
authors.forename: E
authors.initials: E
authors.lastname: Kinugasa
authors.forename: F
authors.initials: F
authors.lastname: Nakayama
authors.forename: T
authors.initials: T
authors.lastname: Takahashi
authors.forename: S
authors.initials: S
authors.lastname: Koshikawa
authors.forename: N
authors.initials: N
authors.lastname: Shimizu
mesh_terms: D000328:Adult; D000740:Anemia / Q000503:physiopathology* / Q000628:therapy; D004702:Endocrine Glands / Q000502:physiology*; D004921:Erythropoietin / Q000009:adverse effects* / Q000627:therapeutic use; D005260:Female; D012739:Gonadal Steroid Hormones / Q000097:blood; D006400:Hematocrit; D006801:Humans; D008297:Male; D008875:Middle Aged; D010907:Pituitary Hormones / Q000097:blood; D011994:Recombinant Proteins / Q000009:adverse effects / Q000627:therapeutic use; D006435:Renal Dialysis / Q000009:adverse effects*; D012723:Sex; D012737:Sex Factors
chemical_list: D012739:Gonadal Steroid Hormones; D010907:Pituitary Hormones; D011994:Recombinant Proteins; D004921:Erythropoietin